Cumberland Pharmaceuticals (CPIX) Change in Receivables (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Change in Receivables data on file, last reported at -$2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 121.07% year-over-year to -$2.7 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (up 1221.02% YoY), and the FY2025 full-year result was $5.2 million, up 169.82% from the prior year.
• Change in Receivables slipped to -$2.7 million in Q1 2026, from $6.5 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $7.8 million in Q1 2022 to a low of -$2.7 million in Q1 2026.
• A 5-year average of $424381.9 and a median of -$171014.0 in 2025 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables soared 4421.45% in 2022 and plunged 666.56% in 2024, its largest moves.
• Tracing CPIX's Change in Receivables over 5 years: stood at -$2.1 million in 2022, then slipped by 21.54% to -$2.5 million in 2023, then surged by 115.54% to $390841.0 in 2024, then jumped by 1566.71% to $6.5 million in 2025, then tumbled by 141.18% to -$2.7 million in 2026.
• Business Quant data shows CPIX's Change in Receivables at -$2.7 million in Q1 2026, $6.5 million in Q4 2025, and $113691.0 in Q3 2025.